John, Linu Mary
Petersen, Natalia
Gerstenberg, Marina Kjærgaard
Torz, Lola https://orcid.org/0000-0001-6013-3081
Pedersen, Kent
Christoffersen, Berit Østergaard
Kuhre, Rune Ehrenreich https://orcid.org/0000-0003-4787-340X
Funding for this research was provided by:
Novo Nordisk
Article History
Received: 11 February 2022
Accepted: 25 August 2022
First Online: 10 September 2022
Competing interests
: The authors declare the following competing interest: all authors are employed by Novo Nordisk (Denmark), and some are minor shareholders of Novo Nordisk stocks. All authors declare no competing interests that may be of relevance to this work.